WASHINGTON, October 30, 2025 — GO2 for Lung Cancer (GO2) announced that David A. Feldman has been elected to its board of directors. Mr. Feldman is an experienced attorney with expertise in investigations, litigation, compliance, and risk management. He currently serves as Deputy Director [...]
By Andrew Ciupek and Brittney Nichols The GO2 team attended the 2025 World Conference on Lung Cancer, where researchers from around the world shared the latest findings and breakthroughs in lung cancer research. Here are some of the key updates [...]
On October 2, 2025, the U.S. Food and Drug Administration (FDA) approved Zepzelca (lurbinectedin) in combination with Tecentriq (atezolizumab) or Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) as maintenance therapy for adult patients with extensive-stage small cell lung cancer (ES-SCLC) whose disease [...]
It’s heartbreaking that our elected leaders can’t find common ground on something as important as the health and well-being of the cancer community. A government shutdown once again puts vital lung cancer research and access to care at risk. This [...]
On September 19, 2025, the U.S. Food and Drug Administration (FDA) approved a new administration method for Keytruda (pembrolizumab). Under the new approval, Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) can now be given by subcutaneous injection, commonly known as a shot, [...]
The World Conference on Lung Cancer (WCLC) is the largest and most influential global gathering focused entirely on lung cancer. This year, the conference will be held in Barcelona, Spain, where researchers, clinicians, and advocates from around the world [...]
Did you know? HER2 is a gene found in cells that is important for cell growth and survival. You may also sometimes see HER2 referred to by the name ERBB-2. In some people, the HER2 gene begins to mutate [...]
SAN CARLOS, CA – July 26, 2025 — GO2 for Lung Cancer (GO2) and the Addario Lung Cancer Medical Institute (ALCMI) are proud to announce that Karen Kelly, MD, chief executive officer of the International Association for the Study [...]
Did you know? EGFR is a gene found in cells that is important for cell growth and survival. In some people, the EGFR gene begins to mutate or change, which can be a driving cause of cancer. There are [...]
This spring has marked a turning point in Washington, D.C. as Congress focuses its attention on a sweeping reconciliation bill known as the "One Big Beautiful Bill Act." The bill has delayed progress on the Fiscal Year 2026 appropriations [...]